Picture of Nkarta logo

NKTX — Nkarta News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Nkarta Inc reports results for the quarter ended December 31 - Earnings Summary

Nkarta Inc NKTX.OQ reported a quarterly adjusted loss of 35 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -57 cents.  The mean expectation of eight analysts for the quarter was for a loss of 41 cents per share. Wall Street expected results to range from -46 cents to -36 cents per share.

Reported revenue was zero​; analysts expected zero.

Nkarta Inc's reported EPS for the quarter was a loss of 35 cents​.

The company reported a quarterly loss of $25.94 million.

Nkarta Inc shares had fallen by 42.6% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 1.9% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The average consensus recommendation for the biotechnology & medical research peer group is  "buy."

Wall Street's median 12-month price target for Nkarta Inc is $15.00

This summary was machine generated from LSEG data March 26 at 08:13 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Dec. 31 2024-0.41-0.35Beat
Sep. 30 2024-0.36-0.39Missed
Jun. 30 2024-0.45-0.34Beat
Mar. 31 2024-0.56-0.58Missed

Recent news on Nkarta

See all news